As patients wait for Philips to take action on the sound-deadening foam used in the manufacture of tens of thousands of ventilators and other respiratory devices, 124 have died and over 21,000 complaints of adverse reactions have been received over exposure to the substance. The Food and Drug Administration recently released the updated numbers as Philips continues to drag its feet on informing the public ...
FDA: Philips Ventilator Foam Killed Over 100
Posted June 9, 2022 in Drug and Medical Device Lawsuits | Product News and Recalls
Philips Threatened with Massive Refunds as FDA Grows Impatient Over Respiratory Devices
Posted May 31, 2022 in Drug and Medical Device Lawsuits | Product News and Recalls
The FDA is not happy with the pace of Philips’ response to an issue with multiple lines of respiratory devices. The corporation recalled millions of the devices almost a year ago and has yet to provide customers at home and at hospitals with a plan to replace the machines that, according to the recall, could be sending carcinogenic foam particles into their lungs and increasing their ...
Citing a need for improvement in the way Philips has handled its duty to notify patients of the recall of a variety of its ventilators and breathing aids, the FDA issued an order to the corporation earlier this month mandating a more open flow of information.
In a statement on the agency’s website, the director of its Center for Devices and Radiological Health acknowledged ...
continue reading...FDA Expands Recall of Philips Ventilators
Posted February 9, 2022 in Drug and Medical Device Lawsuits | Product News and Recalls
More recalls have been ordered for a variety of ventilators made by Dutch electronics and technology manufacturer Philips. The company’s troubles started in fall of last year when lines of Philips CPAPs, BiPAPs, and ventilators were recalled over concerns that the sound dampening foam used in the devices could degrade. This degradation could allow particles of the foam to enter the breathing circuits of the machines and ...
